Related Experiment Video
Updated: Mar 17, 2026
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Zerumbone induces gastric cancer cells apoptosis: Involving cyclophilin A
Abstract:
Gastric cancer is one of the leading causes for cancer death. There is an urgent need to develop new therapeutic approaches targeting metastatic gastric cancer. It has been reported that zerumbone has the anti-cancer effects in various malignant cells. However, the effect and the mechanism of zerumbone on melanoma cells is still largely unknown. In the study, we determined the actions of zerumbone on the human gastric cancer cell line SGC-7901.We also observed the mechanism by which zerumbone induced gastric cancer cell apoptosis. Our data indicated that zerumbone significantly inhibited the growth of human gastric cancer cells in a dose-dependent manner and apoptosis was the main cause of decreased cell viability in zerumbone -treated cells. The treatment with zerumbone downregulated Cyp A and Bcl-2 levels, upregulated Bax levels, and caused Cytochrome c (Cyt-C) to release, activating Caspase-3. In summary, our study suggests that zerumbone mightinduced human gastric cancer cells apoptosis through down-regulating Cyp A and mitochondria-mediated pathways.
Insights
Zerumbone effectively inhibits gastric cancer cell growth by inducing apoptosis. This natural compound targets key proteins, offering a potential new therapy for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Gastric cancer remains a leading cause of cancer mortality worldwide.
- Metastatic gastric cancer necessitates novel therapeutic strategies.
- Zerumbone exhibits anti-cancer properties in various malignant cells, but its mechanism in gastric cancer is unclear.
Purpose of the Study:
- To investigate the anti-cancer effects of zerumbone on the human gastric cancer cell line SGC-7901.
- To elucidate the underlying molecular mechanisms by which zerumbone induces apoptosis in gastric cancer cells.
Main Methods:
- Treatment of SGC-7901 cells with varying concentrations of zerumbone.
- Assessment of cell viability and apoptosis.
- Analysis of protein expression levels (Cyp A, Bcl-2, Bax).
- Measurement of Cytochrome c release and Caspase-3 activation.
Main Results:
- Zerumbone significantly inhibited gastric cancer cell growth in a dose-dependent manner.
- Apoptosis was identified as the primary mechanism for reduced cell viability.
- Zerumbone downregulated Cyp A and Bcl-2, while upregulating Bax.
- Zerumbone treatment led to Cytochrome c release and Caspase-3 activation.
Conclusions:
- Zerumbone induces apoptosis in human gastric cancer cells.
- The mechanism involves the downregulation of Cyp A and activation of the mitochondrial pathway.
- Zerumbone shows potential as a therapeutic agent for gastric cancer.
Related Concept Videos
02:34Inhibition of Cdk Activity
01:31The Intrinsic Apoptotic Pathway
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...